Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia

Pharmacogenetics and Genomics

Volumn 19, Issue 1, 2009, Pages 91-94

  Mössner, Rainald ^a   Schuhmacher, Anna ^a   Kühn, Kai Uwe ^a   Cvetanovska, Gabriela ^a   Rujescu, Dan ^b   Zill, Peter ^b   Quednow, Boris B ^a   Rietschel, Marcella ^c   Wölwer, Wolfgang ^d   Gaebel, Wolfgang ^d   Wagner, Michael ^a   Maier, Wolfgang ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Atypical antipsychotic; HTM A; Negative symptoms; Schizophrenia; Serotonin; Serotonin 1A

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BIFEPRUNOX; CLOZAPINE; HALOPERIDOL; ILOPERIDONE; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN 1A RECEPTOR; ZIPRASIDONE;

ALLELE; AMYGDALOID NUCLEUS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEGATIVE SYNDROME; PHARMACOGENETICS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; GENOTYPE; HALOPERIDOL; HUMANS; MALE; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RECEPTOR, SEROTONIN, 5-HT1A; RISPERIDONE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 58149251983     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e328311a917     Document Type: Article

References (9)

1. Wu S, Comings DE. A common C-1018G polymorphism in the human 5-HT1A receptor gene. Psychiatr Genet 1999; 9:105-106.
2. Burnet PW, Eastwood SL, Harrison PJ. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology 1996; 15:442-455.
3. Frankle WG, Lombardo I, Kegeles LS, Slifstein M, Martin JH, Huang Y, et al. Serotonin 1A receptor availability in patients with schizophrenia and schizoaffective disorder: a positron emission tomography imaging study with [11C]WAY 100635. Psychopharmacology (Bert) 2006; 189:155-164.
4. Yasuno F, Suhara T, Ichimiya T, Takano A, Ando T, Okubo Y. Decreased 5-HT1A receptor binding in amygdala of schizophrenia. Biol Psychiatry 2004; 55:439-444.
5. Gaebel W, Riesbeck M, Wolwer W, Klimke A, Eickhoff M, Von Wilmsdorff M, et al. Maintenance treatment with risperidone or low-dose haloperidol in firstepisode schizophrenia: 1 -year results of a randomized controlled trial within the German Research Network on Schizophrenia. J Clin Psychiatry 2007; 68:1763-1774.
6. Gaebel W, Möller HJ, Buchkremer G, Ohmann C, Riesbeck M, Wölwer W, et al. Pharmacological long-term treatment strategies in first episode schizophrenia - study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia. Eur Arch Psychiatry Clin Neurosci 2004; 254:129-140.
7. Wölwer W, Buchkremer G, Häfner H, Klosterkotter J, Maier W, Möller HJ, et al. German research network on schizophrenia - bridging the gap between research and care. Eur Arch Psychiatry Clin Neurosci 2003; 253:321-329.
8. Reynolds GP, Arranz B, Templeman LA, Fertuzinhos S, San L Effect of 5-HT1A receptor gene polymorphism on negative and depressive symptom response to antipsychotic treatment of drug-naive psychotic patients. Am J Psychiatry 2006; 163:1826-1829.
9. Wang L, Fang C, Zhang A, Du J, Yu L, Ma J, et al. The -1019 C/G polymorphism of the 5-HT1A receptor gene is associated with negative symptom response to risperidone treatment in schizophrenia patients. J Psychopharmacol 2008 Feb 28. [Epub ahead of print] PMID: 18308786.